Table 1.

Baseline characteristics of the participants by treatment group

CharacteristicUsual Care, n=62Home-Based Kidney Care, n=63
Mean or NSD or %Mean or NSD or %
Age, yr48124611
Women, %26423149
Body mass index, kg/m2327328
Diabetes, %39633352
BP, mm Hg
 Systolic1321912917
 Diastolic85138313
Hypertension42683663
High school graduate, %37604166
HbA1c, %7.52.37.52.6
Serum total protein, g/dl7.60.67.70.6
Serum cholesterol, mg/dl1813820158
Serum triglycerides, mg/dla13390–200139100–182
Serum HDL cholesterol, mg/dla5039–634639–62
Serum LDL cholesterol, mg/dl1093211742
eGFR, ml/min per 1.73 m21012910531
Urine ACR, mg/ga19057–71413957–377
hsCRP, mg/La2.61.3–4.13.80.9–10.0
Morisky scoreb4.62.35.42.3
KDQOL measures
 Symptom/problem list86.614.486.411.3
 Effects of kidney disease93.212.092.77.3
 Burden of kidney disease74.323.870.320.5
 SF-12 physical score45.48.545.59.5
 SF-12 mental score51.210.047.49.6
Patient activation total score65.114.660.720.5
Patient activation level ≥352844368
  • HbA1c, hemoglobin A1c; ACR, albumin-to-creatinine ratio; hsCRP, high-sensitivity C-reactive protein; KDQOL, Kidney Disease Quality of Life Survey; SF-12, Short-Form 12 Health Survey.

  • a Median and interquartile range.

  • b Use of the Morisky Medication Adherence Scale is protected by United States copyright laws. Permission for use is required. A license agreement is available from Donald E. Morisky, Department of Community Health Sciences, University of California, Los Angeles School of Public Health, 650 Charles E. Young Drive South, Los Angeles, CA 90095–1772.